About the journal

Journal of Cancer Biomoleculars and Therapeutics (JCBT, EISSN: 3060-8856) is an international, peer-reviewed, open access journal on clinical and experimental research of cancer published quarterly online by ETERNO PRESS SDN. BHD.

• Open Access: This journal operates under a "gold" Open Access model, providing free access to all readers. The Article Processing Charges (APC) for all article types (research, review, case reports) is $50, and the content will be published under a CC BY license. JCBT offers full or partial fee waivers for eligible articles from low- and middle-income economies. For specific APC policies, please refer to the Open Access.
• Recognition of Reviewers: Reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in JCBT, in appreciation of the work done.
• Manuscript Processing Times：
  Submission to first decision: 5-14 days
  Submission to decision after review: 21-90 days
  Submission to acceptance: 30-120 days
  Acceptance to online publication: After acceptance, the manuscript will undergo copyediting and proofreading. Upon completion of these stages, it will be allocated to the nearest available volume and issue and published online subject to the journal's production schedule.

Editor-in-Chief

Pier Paolo Piccaluga, University of Bologna, Italy

Honorary Editor-in-Chief

Olga Sukocheva, Royal Adelaide Hospital, Adelaide, Australia

William CHO Chi Shing, Queen Elizabeth Hospital, Hong Kong, China

Abstracted/indexed in

                                   Lens

General Information

EISSN: 3060-8856

1st Year Published: 2024

Frequency: Quarterly (January, April, July, October)

Issues Per Year: 4

Country / Region: Malaysia

Primary Language: English

Publisher Information: ETERNO PRESS SDN. BHD.